(Q37693666)

22 August 2017

title

Changes in liver biochemistry during methotrexate use for inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

22 August 2017

main subject

0 references

0 references

1 reference

Marc R Fournier

1

1 reference

22 August 2017

Julianne Klein

series ordinal

2

1 reference

22 August 2017

Gerald Y Minuk

series ordinal

3

1 reference

22 August 2017

Charles N Bernstein

series ordinal

4

1 reference

22 August 2017

language of work or name

English

0 references

publication date

16 February 2010

1 reference

The American Journal of Gastroenterology

22 August 2017

published in

1 reference

22 August 2017

volume

105

1 reference

22 August 2017

issue

7

1 reference

22 August 2017

page(s)

1620-1626

1 reference

Pharmacogenetics in inflammatory bowel disease

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.21

Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.21

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.21

Low dose methotrexate in inflammatory bowel disease: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.21

Methotrexate for inflammatory bowel disease: pharmacology and preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.21

The use of low dose methotrexate in rheumatoid arthritis - are we entering a new era of therapeutic drug monitoring and pharmacogenomics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.21

Drug safety in Crohn's disease therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.21

Methotrexate induced liver cirrhosis. Studies including serial liver biopsies during continued treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.21

A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Update after a mean of fifty-three months

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.21

Methotrexate in psoriasis: consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.21

Efficacy of parenteral methotrexate in refractory Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.21

Methotrexate in refractory Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.21

The efficacy of methotrexate for maintaining remission in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.21

Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.21

Long-term tolerability of methotrexate at doses exceeding 15 mg per week in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.21

Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.21

Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.21

Methotrexate and histologic hepatic abnormalities: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.21

Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.21

Methotrexate in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.21

Methotrexate for the Treatment of Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.21

21 January 2018

Identifiers

DOI

10.1038/AJG.2010.21

1 reference

22 August 2017

1 reference